- Forest Labs., Inc. v. Teva Pharms. USA, Inc.
- December 10, 2017Leveraged Products For Retail Investors Pose Hidden Risks
- 2017Brand Name Preemption: The New Frontier in Pharmaceutical Product Liability Litigation
- December 1, 2017How ITC Applied Inter Partes Review Estoppel In Ford Case
- Centuries of Precedent are Little Help as IPR Constitutionality Divides Justices
- The Brave New World of In-Home Delivery Systems
- November 27, 2017Home Sharing – A Growing Market for Liability Insurers
- November 27, 2019Spoofed Emails Armed With Hidden Code: A Terrible, Horrible, No Good, Very Bad Day
- November 27, 2019The Struggle is Real: Managing the Risks to Privacy Posed by Drones
- Eli Lilly and Co. v. Perrigo Co.
- December 2017Home Sharing – A Growing Market for Liability Insurers
- December 2017Spoofed Emails Armed With Hidden Code: A Terrible, Horrible, No Good, Very Bad Day
- December 2017Gender Disparity in the Workplace: Helping Companies to Close the Gap
- Winter 2017The Struggle is Real: Managing the Risks to Privacy Posed by Drones
- Brigham & Women’s Hospital, Inc. v. Perrigo Co.
- Winter 2017Drones: The FAA's Efforts for Timely Integration into Society
- November 16, 2017Ezekiel Elliott’s Run Through Federal Courts
- Journalism Organization Petitions for Resolution of the Copyright Application v. Registration Debate
- Galderma Labs., L.P. v. Teva Pharms USA, Inc.
- Sanofi v. Watson Labs. Inc.
- November 9, 2017Black Ops, Malterial Girls and Golden Tickets: Kerfuffles over Craft Beer Trademarks Continue
- Otsuka Pharm. Co. v. Mylan Inc.
- Bayer Pharma AG v. Watson Labs., Inc.
- November 2017Maximising Return on Investment in a Rapidly Transforming Environment
- Fall 2017Generic Launches
- Fall 2017New ANDA Cases
- Fall 2017ANDA Litigation Settlements
- Merck Sharp & Dohme Corp. v. Hospira, Inc.
- Allergan Sales, LLC v. Teva Pharms. USA, Inc.
- Sanofi v. Lupin Atl. Holdings S.A.
- Bristol-Myers Squibb Co. v. Mylan Pharms., Inc.
- Ferring Pharms. Inc. v. Par Pharm., Inc.
- Fall 2017ANDA Approvals
- Pfizer Inc. v. Mylan Pharms. Inc.
- Mallinckrodt Hosp. Prods. IP Ltd. v. Praxair Distrib., Inc.
- Allergan Sales, LLC v. Teva Pharms. USA, Inc.
- Supernus Pharms., Inc. v. TWi Pharms., Inc.
- Kowa Co. Ltd. v. Amneal Pharms. LLC
- Reckitt Benckiser Pharms., Inc. v. Dr. Reddy’s Labs. S.A.
- In re Sebela Patent Litigation
- Allergan, Inc. v. Teva Pharms. USA, Inc.
- Horizon Pharma, Inc. v. Dr. Reddy’s Labs., Inc.
- Millennium Pharms., Inc. v. Sandoz Inc.
- Merck Sharp & Dohme Corp. v. Actavis Labs. Fl, Inc.
- Reckitt Benckiser LLC v. Amneal Pharms. LLC
- Tris Pharma, Inc. v. Actavis Labs. FL, Inc.
- Merck Sharp & Dohme B.V. v. Warner Chilcott Co., LLC
- The Future of Standard-Essential Patents and the ITC
- Orexigen Therapeutics, Inc. v. Actavis Laboratories Fl, Inc.
- “I’m Unavailable to Take Your Advertisement Right Now”: FCC Regulation of Direct-To-Voicemail Marketing
